Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

January-February 2013; Volume 10,Issue 1
  • You have access
    The Intriguing Options of Multispecific Antibody Formats for Treatment of Cancer
    ULRICH H. WEIDLE, GEORG TIEFENTHALER, ELISABETH H. WEISS, GUY GEORGES and ULRICH BRINKMANN
    Cancer Genomics & Proteomics January 2013, 10 (1) 1-18;
  • You have access
    Genomics and Proteomics Approaches for Biomarker Discovery in Sporadic Colorectal Cancer with Metastasis
    MARÍA GONZÁLEZ-GONZÁLEZ, JACINTO GARCIA GARCIA, JOSÉ ANTONIO ALCAZAR MONTERO, LUIS MIGUEL GONZÁLEZ FERNANDEZ, OSCAR BENGOECHEA, OSCAR BLANCO MUÑEZ, ALBERTO ORFAO, J.M. SAYAGUES and MANUEL FUENTES
    Cancer Genomics & Proteomics January 2013, 10 (1) 19-25;
  • You have access
    Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
    INGIRIDUR SKIRNISDOTTIR and TOMAS SEIDAL
    Cancer Genomics & Proteomics January 2013, 10 (1) 27-34;
  • You have access
    Identification by High-throughput In Silico Screening of Radio-protecting Compounds Targeting the DNA-binding Domain of the Tumor Suppressor p53
    TOLGA EICHHORN, CORINNA HILLER, KERSTIN HIRSCHFELDER, MARTIN FRANK, R. LUISE KRAUTH-SIEGEL, ROLF MÜLLER, ROLF MERTENS and THOMAS EFFERTH
    Cancer Genomics & Proteomics January 2013, 10 (1) 35-45;
  • You have access
    The Differential Expression of Vascular Endothelial Growth Inhibitor Isoforms, VEGI251, VEGI174 and VEGI192 in Human Clear-cell Renal Cell Carcinoma
    NING ZHANG, PENGJIE WU, LIYANG WU, DUOERKUN SHAYIREMU, HUI SHAN, LIN YE, WEN G. JIANG, KAN GONG and YONG YANG
    Cancer Genomics & Proteomics January 2013, 10 (1) 47-53;
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 10 (1)
Cancer Genomics & Proteomics
Vol. 10, Issue 1
January-February 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire